Zarbio is focused on discovering pathophysiology-based treatments for neurodegeneration. We created an experimental platform to study cellular membrane damage induced by misfolding proteins, such as beta-amyloid, which is a prime suspect in Alzheimer's disease. Our research has allowed us to advance the membrane channel theory of neurodegeneration and find new pharmacological targets for treatment.
| Employees | 1 (1 on RocketReach) |
| Founded | 2018 |
| Industry | Research Services |
Looking for a particular Zarbio employee's phone or email?
Dmitry Zaretsky is the Founder, Principal Scientist of Zarbio.
1 people are employed at Zarbio.